CRO Governance Model for Emerging & Virtual Biopharma

Description

Regulatory requirements have significantly lengthened and complicated clinical trials, resulting in an 11% annual rise in clinical testing expenses and delays in FDA submission. Because of their scale and cost advantages, the virtual company model has attracted more and more biotech companies. They attempt to avoid these huge clinical testing expenses by outsourcing their clinical trial management to Contract Research Organizations (CROs). But operating virtually represents challenges to both biotech company and CRO management. This webinar benefits executives looking for organizational strategies to optimize the relationship with the sponsor company to achieve positive clinical trial endpoints.

After going over the emerging virtual company trends, the speaker will discuss strategies to achieve a successful CRO governance model for emerging and virtual biopharma companies. The webinar attendees will learn how to implement responsive communication and get some effective tools to monitor the CRO-Sponsor relationship.

Speaker: Matthew Smith, VP of Business Operations at Clinovo

Agenda:

Industry overview
Virtual company model
Collective goals
Governance model framework
Tools for success
Q&A

No related posts.